Dieser Biotech-ETF verspricht hohe Rendite bei moderatem Risiko

Insgesamt bildet der iShares Nasdaq Biotechnology ETF (IBB) rund 200 Unternehmen physisch repliziert ab, er hält die jeweiligen …
(Orginal – Story lesen…)



This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
526